Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Andrew Dickinson
Age : 51
Public asset : 2,760,269 USD
Country of residence : Unknown
Linked companies : Gilead Sciences, Inc. - Immunomedics, Inc. - Forty Seven, Inc.

Biography of Andrew Dickinson 
Mr. Andrew D. Dickinson is a President, Treasurer & Director at Immunomedics, Inc., a President, Treasurer & Director at Forty Seven, Inc. and a Chief Financial Officer at Gilead Sciences, Inc. He is on the Board of Directors at Immunomedics, Inc., Forty Seven, Inc., Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. Mr. Dickinson was previously employed as a Founding Partner by Kendall Dickinson & Koenig LLC, a Secretary, Vice President & General Counsel by Myogen, Inc., and a Co-Head-Healthcare Investment Banking by Lazard Ltd. He received his undergraduate degree from The University of Colorado and a graduate degree from Loyola University of Chicago.


Current positions of Andrew Dickinson 
Holdings of Andrew Dickinson 
Andrew Dickinson : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Andrew Dickinson : Connections 


Latest news about Andrew Dickinson 
2020GILEAD SCIENCES : cuts 2020 sales outlook as COVID-19 drug remdesivir falls short
RE
2020Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update
DJ
2020GILEAD SCIENCES : cuts 2020 sales outlook as COVID-19 drug remdesivir falls short
T3
2019Gilead Sciences, Inc. Appoints Andrew Dickinson as Chief Financial Officer, Effective November 1, 2019
CI
2018Gilead Sciences, Inc. Announces Executive Changes
CI
2017Gilead Sciences, Inc. completed the acquisition of Kite Pharma, Inc..
CI
2017Gilead Sciences, Inc. entered into a definitive agreement to acquire Kite Pharma, Inc. for $10.4 billion.
CI
More news